19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
In a predictable decision, the Fifth Circuit has held that the availability of class arbitration is ...
Read More >
Romanian government details UK citizens’ residence, employment and travel rights in case of a no-de...
Read More >
French law No. 2018-771 of September 5, 2018, which is a law “for the freedom to choose one’s prof...
Read More >
State pay equity laws, in large part, has been a response to a perception that the federal governmen...
Read More >
If you’re an employer in Maryland, beginning October 1, 2019, you are prohibited from requiring a l...
Read More >